Rival pharma company Novo Nordisk has hit back at Lilly, with Jamey Millar , Executive Vice President for US operations, saying: "Not all GLP-1s are the same." Any reports claiming orforglipron is more effective than Wegovy pill for weight management are inaccurate and misleading
Nausea is common on a GLP1, especially in your first few months
Most patients in the ACHIEVE trials who experienced GI symptoms found them manageable, and discontinuation rates due to side effects were in the 5-8% range, similar to injectable alternatives
Compared to primary SG, both primary GB and DS were associated with higher odds of readmission (OR 1.96 [1.90, 2.01] and 1.78 [1.58, 2.01] respectively), reoperation (OR 2.68 [2.55, 2.81] and 3.24 [2.73, 3.85]), and SSI (3.21 [2.92, 3.33] and 4.13 [4.35, 5.08])
Prospective trials are needed to confirm whether these medications directly affect eye disease risk. He noted that we may see more unexpected effects, some of which could be beneficial for eye health, as GLP-1 medications become more widely used
It is also common with kidney infections